Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Intersurgical, a global medical device company focused on anaesthesia and respiratory care, has announced an agreement to acquire Teleflex’s Acute Care and Interventional Urology businesses. The transaction is positioned as a strategic step to expand Intersurgical’s product range.
Intersurgical expects to integrate the acquired urology product ranges, technical expertise, and operations to deliver a broader portfolio to customers and distribution partners worldwide. The company said it will bring the Teleflex Acute Care and Interventional Urology teams into its organization, and it views the brands as world-class and synergistic with Intersurgical’s existing range.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026